Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4558445
Max Phase: Preclinical
Molecular Formula: C8H17N3
Molecular Weight: 155.25
Molecule Type: Unknown
Associated Items:
ID: ALA4558445
Max Phase: Preclinical
Molecular Formula: C8H17N3
Molecular Weight: 155.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CCC(=N)NCCCCN
Standard InChI: InChI=1S/C8H17N3/c1-2-5-8(10)11-7-4-3-6-9/h2H,1,3-7,9H2,(H2,10,11)
Standard InChI Key: UHRBMIUEKLWEPB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 155.25 | Molecular Weight (Monoisotopic): 155.1422 | AlogP: 0.87 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.90 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 12.33 | CX LogP: -0.06 | CX LogD: -4.86 |
Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.23 | Np Likeness Score: 0.36 |
1. Lunk I, Litty FA, Hennig S, Vetter IR, Kotthaus J, Altmann KS, Ott G, Havemeyer A, Carrillo García C, Clement B, Schade D.. (2020) Discovery of N-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1)., 63 (1): [PMID:31841335] [10.1021/acs.jmedchem.9b01230] |
Source(1):